Pharma-Grade Propellant Gases (HFA-134a)
$0.08 bnAnnual import
10%Indian capability
4,950Supplier concentration (HHI)
₹1,000 crTo localise
Why India imports it. Chemours, Honeywell dominate; India has no production.
Why it matters. Asthma inhaler market; 30M+ patients in India.
Can India localise it? Partial - 4-5 years.
Where it comes from. USA (65%), China (25%), Japan (10%).
Scorecard
The ten indices
CMDI 64.75Dependency
LPI 42.25Localisation potential
IAI 66.25Investment attractiveness
SRI 68Supply risk
SCI 53Supply-chain complexity
TRI 44.5Technology readiness
IMI 66.5Industrial multiplier
NSRI 56.5National-security relevance
EPI 65.25Export potential
ICGI 63.5Capability gap
Who makes it
Manufacturers
In India
SRF Limited
Global leaders
ChemoursHoneywell
Intelligence
Related signals
Sources
Primary references
Confidence: Reasoned estimate. Reasoned estimate. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).